A detailed history of Prosight Management, LP transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Prosight Management, LP holds 554,103 shares of SNDX stock, worth $7.24 Million. This represents 2.86% of its overall portfolio holdings.

Number of Shares
554,103
Previous 551,544 0.46%
Holding current value
$7.24 Million
Previous $11.3 Million 5.8%
% of portfolio
2.86%
Previous 3.54%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$17.93 - $24.81 $45,882 - $63,488
2,559 Added 0.46%
554,103 $10.7 Million
Q2 2024

Aug 14, 2024

BUY
$18.82 - $23.79 $10.4 Million - $13.1 Million
551,544 New
551,544 $11.3 Million

Others Institutions Holding SNDX

About Syndax Pharmaceuticals Inc


  • Ticker SNDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,565,200
  • Market Cap $739M
  • Description
  • Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...
More about SNDX
Track This Portfolio

Track Prosight Management, LP Portfolio

Follow Prosight Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prosight Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Prosight Management, LP with notifications on news.